메뉴 건너뛰기




Volumn 100, Issue 11, 2008, Pages 826-827

Re: Prospective study of vitamin D and cancer mortality in the United States [2]

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VITAMIN D;

EID: 44949114213     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn041     Document Type: Letter
Times cited : (8)

References (7)
  • 1
    • 36048995436 scopus 로고    scopus 로고
    • Prospective study of vitamin D and cancer mortality in the United States
    • Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007;99(21):1594-1602.
    • (2007) J Natl Cancer Inst , vol.99 , Issue.21 , pp. 1594-1602
    • Freedman, D.M.1    Looker, A.C.2    Chang, S.C.3    Graubard, B.I.4
  • 2
    • 23844499356 scopus 로고    scopus 로고
    • Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer
    • Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991-1997.
    • (2005) Cancer Epidemiol Biomarkers Prev , vol.14 , Issue.8 , pp. 1991-1997
    • Bertone-Johnson, E.R.1    Chen, W.Y.2    Holick, M.F.3
  • 3
    • 19444366494 scopus 로고    scopus 로고
    • Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population
    • Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164-1169.
    • (2005) Eur J Cancer , vol.41 , Issue.8 , pp. 1164-1169
    • Lowe, L.C.1    Guy, M.2    Mansi, J.L.3
  • 4
    • 38849189248 scopus 로고    scopus 로고
    • Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer - results of a large case-control study
    • Abbas S, Linseisen J, Slanger T, et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer - results of a large case-control study. Carcinogenesis. 2008;29(1):93-99.
    • (2008) Carcinogenesis , vol.29 , Issue.1 , pp. 93-99
    • Abbas, S.1    Linseisen, J.2    Slanger, T.3
  • 6
    • 35148872638 scopus 로고    scopus 로고
    • What is the dose-response relationship between vitamin D and cancer risk?
    • Garland CF, Grant WB, Mohr SB, Gorham ED, Garland FC. What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev. 2007;65(8 pt 2):S91.
    • (2007) Nutr Rev , vol.65 , Issue.8 PART 2
    • Garland, C.F.1    Grant, W.B.2    Mohr, S.B.3    Gorham, E.D.4    Garland, F.C.5
  • 7
    • 34250015299 scopus 로고    scopus 로고
    • Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial
    • Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586-1591.
    • (2007) Am J Clin Nutr , vol.85 , Issue.6 , pp. 1586-1591
    • Lappe, J.M.1    Travers-Gustafson, D.2    Davies, K.M.3    Recker, R.R.4    Heaney, R.P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.